Ani Pharmaceuticals Inc (ANIP)
Other Income/Expenses (Net)
-$3.36M
Quarterly · Period ending: · USD
ANIP Other Income/Expenses (Net)
Latest reported-$3.36Mperiod ending
Latest reported-$3.36Mperiod ending
ANIP Quarterly Other Income/Expenses (Net) ($0.00 → -$3.36M)
Quarterly Other Income/Expenses (Net)
High-resolution chart · PNG
ANIP other income/expenses (net) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| -3,363,000 | |
| 1,515,000 | |
| -16,696,000 | |
| 10,968,000 | |
| -3,367,000 | |
| -6,207,000 | |
| -9,384,000 | |
| -10,979,000 | |
| -7,456,000 | |
| 5,023,000 | |
| -5,779,000 | |
| -6,437,000 | |
| -7,153,000 | |
| -7,730,000 | |
| -7,548,000 | |
| -7,227,000 | |
| -5,905,000 | |
| -6,702,000 | |
| -7,130,000 | |
| -3,568,000 | |
| -2,598,000 | |
| -2,969,000 | |
| -2,713,000 | |
| -2,739,000 | |
| -2,472,000 | |
| -2,022,000 | |
| -2,981,000 | |
| -3,369,000 | |
| -3,360,000 | |
| -3,484,000 | |
| -4,105,000 | |
| -3,748,000 | |
| -3,760,000 | |
| -3,695,000 | |
| -3,029,000 | |
| -2,957,000 | |
| -3,044,000 | |
| -2,950,000 | |
| -2,902,000 | |
| -2,877,000 | |
| -2,842,000 | |
| -2,780,000 | |
| -2,767,000 | |
| -2,794,000 | |
| -2,749,000 | |
| -2,657,000 | |
| -712,000 | |
| 92,000 | |
| -36,000 | |
| 29,000 | |
| 31,000 | |
| 147,709 | |
| -808,166 | |
| 651,860 | |
| -1,038,258 | |
| -786,849 | |
| -7,452,896 | |
| -3,332,542 | |
| 1,905,573 | |
| 294,516 | |
| -1,910,289 | |
| -807,755 | |
| 0 | |
| -183,000 | |
| -554,000 | |
| -1,581,000 | |
| -33,122,801 | |
| -1,470,467 | |
| 0 | |
| 11,648 | |
| 693,667 | |
| 105,751 | |
| -534,353 | |
| 340,977 | |
| 339,313 | |
| 379,114 | |
| 230,488 | |
| 146,529 | |
| -1,131,832 | |
| 0 | |
| 55,000 | |
| 96,179 | |
| 1,792,666 | |
| 104,390 | |
| 101,926 | |
| 97,947 | |
| -20,072,684 | |
| 84,584 | |
| 55,599 | |
| 0 | |
| 1,746,257 | |
| 0 | |
| 0 | |
| 65,494 | |
| -3,399,291 | |
| 0 | |
| 643,163 | |
| 0 | |
| -1,171,014 | |
| 0 |